Abiopharma

🔍 Mitchell Thomas Duncan (Director)

Company: AerSale Corp (ASLE)

Report Date: 2026-06-05

Detailed Transactions and Holdings:

• Acquired 19,623 shares of Common Stock (Direct)
  Date: 2026-06-05 | Code: A | equity_swap_involved: 0 | shares_owned_after: 43,880.00 | transaction_form_type: 4 | Footnotes: F1

Footnotes:

• F1: Represents an award of restricted stock units granted under the Second Amended and Restated Non-Employee Director Compensation Policy, which will vest 100% on 6/05/2027, subject to continued service on the Issuer's Board of Directors through such date. Each restricted stock unit will convert into one share of the Issuer's common stock upon vesting.